Sana Biotechnology, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €80.18M +252.5% -€213.62M -16.2% -266.4% +8.5 pp N/A N/A
    (estimated) €22.74M +∞% -€255.02M +16.7% -1,121.2% -11 pp N/A N/A
    (estimated) €0.00 +NaN% -€218.46M +18.9% N/A -€166.05M +8.2% N/A
    (estimated) €0.00 +NaN% -€183.79M +2.1% N/A -€153.53M +8.8% N/A
    (estimated) €0.00 +NaN% -€180.09M -21.6% N/A -€141.14M -13.7% N/A
    €0.00 +NaN% -€229.83M -5.8% N/A -€163.46M -18.8% N/A
    €0.00 +NaN% -€244.04M +5.1% N/A -€201.21M -13.2% N/A
    €0.00 +NaN% -€232.17M -24.3% N/A -€231.91M +21.7% N/A
    €0.00 +NaN% -€306.65M +24.8% N/A -€190.57M +93.8% N/A
    €0.00 +NaN% -€245.80M +118.2% N/A -€98.31M +92.4% N/A
    €0.00 +NaN% -€112.67M +887.2% N/A -€51.11M +355.1% N/A
    €0.00 -€11.41M N/A -€11.23M N/A

    Notifications